The blood-brain barrier choline transporter as a brain drug delivery vector

Life Sciences

Volumn 73, Issue 13, 2003, Pages 1609-1615

  Allen, D D ^a   Lockman, P R ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIUM DERIVATIVE; CHOLINE DERIVATIVE; NICOTINE;

BINDING AFFINITY; BLOOD BRAIN BARRIER; BRAIN PERFUSION; CENTRAL NERVOUS SYSTEM; CHOLINE UPTAKE; CHOLINERGIC SYSTEM; DIFFUSION; DRUG DELIVERY SYSTEM; HUMAN; MOLECULAR INTERACTION; PARENCHYMA; REVIEW; TRANSPORT KINETICS;

EID: 0037559607     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(03)00504-6     Document Type: Review

References (35)

1. U.S. Food and Drug Administration, 2001. Nutrient content claims notification for choline containing foods. Aug. 30. Available at http://vm.cfsan.fda.gov/~dms/flcholin.html.
2. Allen D.D., Smith Q.R. Characterization of the blood-brain barrier choline transporter using the in situ rat brain perfusion technique. Journal of Neurochemistry. 76(4):2001;1032-1041.
3. Allen D.D., Lockman P.R., Roder K.E., Dwoskin L.P., Crooks P.A. Active transport of high affinity choline and nicotine analogs into the central nervous system by the blood-brain barrier choline transporter. The Journal of Pharmacology and Experimental Therapeutics. 304:2003;1268-1274.
4. Ansell G.B., Spanner S. Studies on the origin of choline in the brain of the rat. The Biochemical Journal. 122(5):1971;741-750.
5. Brightman M.W. Morphology of blood-brain interfaces. Experimental Eye Research. 25:1977;1-25. (Suppl).
6. Buchman A.L., Sohel M., Brown M., Jenden D.J., Ahn C., Roch M., Brawley T.L. Verbal and visual memory improve after choline supplementation in long-term total parenteral nutrition: A pilot study. Journal of Parenteral and Enteral Nutrition. 25(1):2001;30.
7. Butt A.M., Jones H.C., Abbot N.J. Electrical resistance across the blood-brain barrier in anaesthetized rats: a developmental study. Journal of Physiology. 429:1990;47-62.
8. Cornford E.M., Braun L.D., Oldendorf W.H. Carrier mediated blood-brain barrier transport of choline and certain analogs. Journal of Neurochemistry. 30(2):1978;299-308.
9. 3H]-dopamine release by pyridino N-substituted nicotine analogues: A new class of nicotinic antagonist. Drug Development research. 36:1995;91-102.
10. Diamond I. Choline metabolism in the central nervous system: the role of choline transport from plasma to brain. Neurology. 20(4):1970;382.
11. Dwoskin L.P., Crooks P.A. Competitive neuronal nicotinic receptor antagonists: a new direction for drug discovery. The Journal of Pharmacology and Experimental Therapeutics. 298(2):2001;395-402.
12. Estrada C., Bready J., Berliner J., Cancilla P.A. Choline uptake by cerebral capillary endothelial cells in culture. Journal of Neurochemistry. 54(5):1990;1467-1473.
13. Fenart L., Casanova A., Dehouck B., Duhem C., Slupek S., Cecchelli R., Betbeder D. Evaluation of effect of charge and lipid coating on ability of 60 nm nanoparticles to cross an in vitro model of the blood-brain barrier. The Journal of Pharmacology and Experimental Therapeutics. 291(3):1999;1017-1022.
14. Friedrich A., George R.L., Bridges C.C., Prasad P.D., Ganapathy V. Transport of choline and its relationship to the expression of the organic cation transporters in a rat brain microvessel endothelial cell line (RBE4). Biochimica et biophysica acta. 1512(2):2001;299-307.
15. Goldenberg G.J., Begleiter A. Membrane transport of alkylating agents. Pharmacology and Therapeutics. 8(2):1980;237-274.
16. Kang Y.S., Terasaki T., Ohnishi T., Tsuji A. In vivo and in vitro evidence for a common carrier mediated transport of choline and basic drugs through the blood-brain barrier. Journal of Pharmacobio-Dynamics. 13(6):1990;353-360.
17. Klein J., Koppen A., Loffelholz K., Schmitthenner J. Uptake and metabolism of choline by rat brain after acute choline administration. Journal of Neurochemistry. 58(3):1992;870-876.
18. Lockman P.R., Allen D.D. The transport of choline: A review. Drug Development and Industrial Pharmacy. 28(7):2002;749-771.
19. Lockman P., Mumper R., Kahn M., Allen D.D. Nanoparticle technology for drug delivery across the blood-brain barrier. Drug Development and Industrial Pharmacy. 28(1):2002;1-13.
20. Lockman P.R., Roder K.E., Allen D.D. Inhibition of the rat blood-brain barrier choline transporter by manganese chloride. Journal of Neurochemistry. 79(3):2001;588-594.
21. Metting T.L., Burgio D.E., Terry A.V., Beach J.W., McCurdy C.R., Allen D.D. Inhibition of brain choline uptake by isoarecolone and lobeline derivatives: implications for potential vector-mediated brain drug delivery. Neuroscience Letters. 258(1):1998;25-28.
22. Montoya D., Swartzwelder H.S. Prenatal choline supplementation alters hippocampal N-methyl-D-aspartate receptor-mediated neurotransmission in adult rats. Neuroscience Letters. 296(2-3):2000;85-88.
23. Murakami H., Sawada N., Koyabu N., Ohtani H., Sawada Y. Characteristics of choline transport across the blood-brain barrier in mice: Correlation with in vitro data. Pharmaceutical Research. 17(12):2000;1526-1530.
24. Pardridge W.M., Oldendorf W.H. Transport of metabolic substrates through the blood-brain Barrier. Journal of Neurochemistry. 28(1):1977;5-12.
25. Simon J.R., Mittag T.W., Kuhar J.M. Inhibition of synaptosomal uptake of choline by various choline analogs. Biochemical Pharmacology. 24(10):1975;1139-1142.
26. Smith Q.R. Advances in neurology. Wurtman R. Alzheimer's Disease. 1990;217-222 Raven Press, New York. 51.
27. Smith Q.R. Drug delivery to the brain and the role of carrier mediated transport. Drewes L.R., Betz A.L. Frontiers in Cerebral Vascular Biology: Transport and its Regulation. 1993;83-93 Plenum Press, New York.
28. Smith Q.R. Drug delivery to brain and the role of carrier-mediated transport. Advances in Experimental Medicine and Biology. 331:1993;83-93.
29. Sawada N., Takanaga H., Matsuo H., Naito M., Tsuruo T., Sawada Y. Choline uptake by mouse brain capillary endothelial cells in culture. The Journal of Pharmacy and Pharmacology. 51(7):1999;847-852.
30. Strecker A. Uber eingige neue Bestandtheile der Schweinegalle. Annuals of Chemical Pharmacie. 183:1862;964-965.
31. Takada Y., Vistica D.T., Greig N.H., Purdon D., Rapoport S.I., Smith Q.R. Rapid high affinity transport of a chemotherapeutic amino acid across the blood-brain barrier. Cancer Research. 52(8):1992;2191-2196.
32. Takasato Y., Rapoport S.I., Smith Q.R. An in situ brain perfusion technique to study cerebrovascular transport in the rat. The American Journal of Physiology. 247(3 Pt 2):1984;H484-H493.
33. Tsubaki H., Komai T. Intestinal absorption of choline in rats. Journal of Pharmacobio-Dynamics. 10(10):1987;571-579.
34. Wilkins L.H. Jr., Haubner A., Ayers J.T., Crooks P.A., Dwoskin L.P. N-n-Alkylnicotinium analogs, a novel class of nicotinic receptor antagonist: inhibition of S(-)-nicotine-evoked [(3)H]dopamine overflow from superfused rat striatal slices. The Journal of Pharmacology and Experimental Therapeutics. 301(3):2002;1088-1096.
35. Yang Y., Liu Z., Cermak J.M., Tandon P., Sarkisian M.R., Stafstrom C.E., Neill J.C., Blusztajn J.K., Holmes G.L. Protective effects of prenatal choline supplementation of seizure-induced memory impairment. The Journal of Neuroscience. 20(22):2000;RC109.